GL1X · GenesisL1 explorer

MolNFT v1 · #49476 · protein

Human nep complexed with a bifunctional NEP/DPP IV inhibitor

2QPJ · Neprilysin: “Human nep complexed with a bifunctional NEP/DPP IV inhibitor”. X-ray diffraction, 3 ligands (I20, NAG, ZN), 11 pockets (best druggability 0.64). MolNFT v1 #49476 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
2QPJ
Type
protein
Length
696 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Neprilysin
EC
3.4.24.11
UniProt
P08473
Ligands
I20, NAG, ZN
Pockets
11 · best druggability 0.64

Structure

x-ray diffraction · 1 distinct chain · 58% helix, 7% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANeprilysin (EC 3.4.24.11)protein69658% helix, 7% strandP08473

Ligands and binding sites

  • I20 · (2S)-2-({(2S)-3-[(R)-[(1R)-1-({(4S)-4-amino-5-[(2S)-2-cyanopyrrolidin-1-yl]-5-oxopentanoyl}amino)ethyl](hydroxy)phosphoryl]-2-benzylpropanoyl}amino)propanoic acid · ligand · chains A
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 3 copies · chains A
  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14620.640.7756empty
21290.630.8728ZN, I20
34010.620.7741empty
41460.490.7828empty
5670.470.8320empty

Modifications

Observed in the structure: 6 disulfide, 3 glycan (disulfide, N-glycosylation).

Compared structures

  • 2QPJ · Human NEP complexed with a bifunctional NEP/DPP IV inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • P08473 · AlphaFold monomer V2.0 prediction for neprilysin (P08473) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.